Advertisement
U.S. markets closed

Cytosorbents Corporation (CTSO)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
0.9661+0.0861 (+9.78%)
At close: 04:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Momentum

Momentum

Previous Close0.8800
Open0.8800
Bid1.0200 x 1100
Ask1.0700 x 1000
Day's Range0.8800 - 0.9900
52 Week Range0.8400 - 4.2900
Volume134,848
Avg. Volume316,921
Market Cap50.403M
Beta (5Y Monthly)0.58
PE Ratio (TTM)N/A
EPS (TTM)-0.6400
Earnings DateApr 30, 2024 - May 06, 2024
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.70
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for CTSO

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Cytosorbents Corporation
    Analyst Report: Illumina, Inc.Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina’s high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (9% of 2023 sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
    Rating
    Fair Value
    Economic Moat
    5 days agoMorningstar
View more